Award
Dana-Farber Cancer Institute RFA-RM-22-011
Single Molecule Detection of L1 Insertions and Intermediates
Recipient
Dana-Farber Cancer Institute
Award Amount
$698,829.00
Ceiling
$698,829.00
Awarded
March 24, 2026
Identifier
RFA-RM-22-011
Award for developing tools to study LINE-1 retrotransposons in human tissues using advanced technologies, funded by NIH/NINDS with a budget of $698,829 for 2026.
Description
This project aims to develop new tools for assessing contributions of LINE-1 (L1) retrotransposons to somatic mosaicism in human tissues, utilizing advanced long-read and single-cell technologies. The award is funded by the NIH/NINDS, with a total budget of approximately $698,829 for the fiscal year 2026. The project duration is from April 1, 2023, to March 31, 2028.